Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 15937332)

1.

Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.

Zhang Z, Olland AM, Zhu Y, Cohen J, Berrodin T, Chippari S, Appavu C, Li S, Wilhem J, Chopra R, Fensome A, Zhang P, Wrobel J, Unwalla RJ, Lyttle CR, Winneker RC.

J Biol Chem. 2005 Aug 5;280(31):28468-75. Epub 2005 Jun 3.

2.

In vitro characterization of trimegestone: a new potent and selective progestin.

Zhang Z, Lundeen SG, Zhu Y, Carver JM, Winneker RC.

Steroids. 2000 Oct-Nov;65(10-11):637-43.

PMID:
11108870
3.

Characterization of a new class of selective nonsteroidal progesterone receptor agonists.

Dong Y, Roberge JY, Wang Z, Wang X, Tamasi J, Dell V, Golla R, Corte JR, Liu Y, Fang T, Anthony MN, Schnur DM, Agler ML, Dickson JK Jr, Lawrence RM, Prack MM, Seethala R, Feyen JH.

Steroids. 2004 Mar;69(3):201-17.

PMID:
15072922
4.

A new generation of progesterone receptor modulators.

Winneker RC, Fensome A, Zhang P, Yudt MR, McComas CC, Unwalla RJ.

Steroids. 2008 Aug;73(7):689-701. doi: 10.1016/j.steroids.2008.03.005. Epub 2008 Mar 28. Review.

PMID:
18472121
5.

Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.

Fensome A, Bender R, Chopra R, Cohen J, Collins MA, Hudak V, Malakian K, Lockhead S, Olland A, Svenson K, Terefenko EA, Unwalla RJ, Wilhelm JM, Wolfrom S, Zhu Y, Zhang Z, Zhang P, Winneker RC, Wrobel J.

J Med Chem. 2005 Aug 11;48(16):5092-5.

PMID:
16078826
6.

The preclinical biology of a new potent and selective progestin: trimegestone.

Winneker RC, Bitran D, Zhang Z.

Steroids. 2003 Nov;68(10-13):915-20. Review.

PMID:
14667983
7.

5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.

Zhang P, Terefenko E, Kern J, Fensome A, Trybulski E, Unwalla R, Wrobel J, Lockhead S, Zhu Y, Cohen J, Lacava M, Winneker RC, Zhang Z.

Bioorg Med Chem. 2007 Oct 15;15(20):6556-64. Epub 2007 Jul 26.

PMID:
17681796
8.

Nonsteroidal progesterone receptor modulators: structure activity relationships.

Winneker RC, Fensome A, Wrobel JE, Zhang Z, Zhang P.

Semin Reprod Med. 2005 Feb;23(1):46-57. Review.

PMID:
15714389
9.

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone.

Lundeen SG, Zhang Z, Zhu Y, Carver JM, Winneker RC.

J Steroid Biochem Mol Biol. 2001 Aug;78(2):137-43.

PMID:
11566438
10.

Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.

Petit-Topin I, Turque N, Fagart J, Fay M, Ulmann A, Gainer E, Rafestin-Oblin ME.

Mol Pharmacol. 2009 Jun;75(6):1317-24. doi: 10.1124/mol.108.054312. Epub 2009 Mar 16.

11.

Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.

Berrodin TJ, Jelinsky SA, Graciani N, Butera JA, Zhang Z, Nagpal S, Winneker RC, Yudt MR.

Biochem Pharmacol. 2009 Jan 15;77(2):204-15. doi: 10.1016/j.bcp.2008.10.016. Epub 2008 Nov 1.

PMID:
19013437
12.

The significance of the 20-carbonyl group of progesterone in steroid receptor binding: a molecular dynamics and structure-based ligand design study.

Hillisch A, von Langen J, Menzenbach B, Droescher P, Kaufmann G, Schneider B, Elger W.

Steroids. 2003 Nov;68(10-13):869-78. Review.

PMID:
14667979
13.

Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.

Yudt MR, Russo LA, Berrodin TJ, Jelinsky SA, Ellis D, Cohen JC, Cooch N, Haglund E, Unwalla RJ, Fensome A, Wrobel J, Zhang Z, Nagpal S, Winneker RC.

Biochem Pharmacol. 2011 Dec 1;82(11):1709-19. doi: 10.1016/j.bcp.2011.08.006. Epub 2011 Aug 11.

PMID:
21854761
14.

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

Sitruk-Ware R, Bossemeyer R, Bouchard P.

Gynecol Endocrinol. 2007 Jun;23(6):310-9. Review.

PMID:
17616854
15.

Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.

Zhang P, Terefenko EA, Fensome A, Wrobel J, Winneker R, Zhang Z.

Bioorg Med Chem Lett. 2003 Apr 7;13(7):1313-6.

PMID:
12657271
16.
17.

The pharmacological profile of a novel norpregnance progestin (trimegestone).

Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M.

Gynecol Endocrinol. 1999 Oct;13(5):316-26.

PMID:
10599548
18.

Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.

Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K.

Steroids. 2008 Feb;73(2):222-31. Epub 2007 Oct 22.

PMID:
18061638
19.

Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.

Palmer S, Campen CA, Allan GF, Rybczynski P, Haynes-Johnson D, Hutchins A, Kraft P, Kiddoe M, Lai M, Lombardi E, Pedersen P, Hodgen G, Combs DW.

J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):33-42.

PMID:
11179906
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk